BETALIQ
Betaliq is a collaboration between Novaliq, GMBH, and BLP Management Group, LLC. It was formed to develop ophthalmic beta-blockers using Novaliq’s patented EyeSol non-water formulation technology. The company is developing two beta-blockers, for the treatment of glaucoma. BTQ 1901 is an EyeSol based formulation of a potent selective beta-blocker that has not previously been used to treat glaucoma. BTQ 1902 is an EyeSol based formulation of timolol, the most commonly prescribed beta-blockers.
BETALIQ
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.betaliq.com
Total Employee:
1+
Status:
Active
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Google Apps For Business GoDaddy DNS GoDaddy Starfield Technologies Adobe Muse Adobe Creative Cloud WebFonts
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Current Employees Featured
Investors List
Brookline Capital Markets
Brookline Capital Markets investment in Seed Round - Betaliq
Official Site Inspections
http://www.betaliq.com Semrush global rank: 3.88 M Semrush visits lastest month: 1.18 K
- Host name: 35.226.229.23.host.secureserver.net
- IP address: 23.229.226.35
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
